OPEN ACCESS: All News
In brief
Cite this as:
BMJ
2005;331:66.1
Colon cancer drugs to be more widely available: The UK National Institute for Health and Clinical Excellence (NICE) has decided that two chemotherapy drugs for advanced bowel cancer, irinotecan and oxaliplatin, should be more widely available to patients. It follows a concerted campaign by Colon Cancer Concern, clinicians, patients, and other groups that have urged NICE to increase access to these …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Should UK membership exams be held overseas? Yes
Published 9 February 2012
Why not use ultrasound for the diagnosis of ovarian cancer for both the exclusion criteria for recruitment and for diagnosis as outcome variable
Published 9 February 2012
Re: Can the severity of menopausal symptoms be predicted?
Published 9 February 2012
Re: Does the BMJ have a particular ideology to pursue in assisted dying?
Published 9 February 2012
Re: Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis
Published 9 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012
How much of a social media profile can doctors have? (5 responses)
Published 23 Jan 2012